Peripheral blood smear from a patient with suspected chronic lymphocytic leukemia (CLL) shows a predominance of small, mature-appearing lymphocytes with scant cytoplasm and clumped nuclear chromatin, accompanied by fragile cells that readily disrupt during smear preparation, producing numerous smudge or basket cells visible on the slide. The image depicts a single smudge cell in the upper right, with numerous small darkly staining lymphocytes occupying the field. The smear was prepared with Wright-Giemsa stain and examined under light microscopy at high magnification (approximately 1000x total magnification with oil immersion). Clinically, CLL is defined by absolute mature lymphocytosis of ≥5.0 × 10^9/L sustained for ≥3 months, often asymptomatic and detected incidentally on complete blood count. Morphology alone is insufficient for diagnosis; immunophenotyping showing co-expression of CD5, CD19, CD23 with weak surface immunoglobulin and light chain restriction supports CLL diagnosis. Smudge cells result from fragile leukemic cells and reflect underlying cytoskeletal fragility, though they are not specific. The image illustrates typical features: monomorphic lymphocytes, scant cytoplasm, condensed chromatin, and absent prominent nucleoli. This finding has diagnostic significance, guiding further workup, including flow cytometry, cytogenetics, and molecular studies, to distinguish CLL from other chronic lymphoproliferative disorders such as small lymphocytic lymphoma (SLL), mantle cell lymphoma, prolymphocytic leukemia, and reactive lymphocytosis.

Peripheral blood smear from a patient with known chronic lymphocytic leukemia (CLL) showing autoimmune hemolytic anemia (AIHA). Brightfield microscopy of Wright-Giemsa stained smear at 1000x (oil immersion) reveals two dominant cell populations: numerous small mature lymphocytes typical of CLL and red blood cells showing spherocytic deformation. A smudge cell is evident just left of center, a classical clue for CLL. Red cells display reduced central pallor consistent with spherocytes, indicating intravascular or extravascular hemolysis driven by autoantibodies. The background shows mild polychromasia and rare nucleated RBCs, consistent with a robust reticulocyte response; the corrected reticulocyte count in this case is markedly elevated (>7%). Platelets are not significantly abnormal. These features collectively support autoimmune destruction of erythrocytes in the setting of CLL. Diagnostic significance lies in recognizing AIHA as a common autoimmune complication in CLL, with a clinical picture of sudden Hb decline and compensatory erythropoiesis. Differential considerations include drug-induced hemolysis, other causes of hemolytic anemia, or marrow infiltration by CLL. Clinical correlation includes therapy implications (steroids, rituximab) and close monitoring of hemolysis markers. This image is a valuable teaching resource for hematology morphology, AIHA in CLL, and differential diagnosis in anemia.

Imaging Modality: Brightfield light microscopy of a Wright-Giemsa stained peripheral blood smear. The primary subject is leukocytes from circulating blood, with focus on small mature-appearing lymphocytes and rare prolymphocytes. At center-right, several lymphocytes exhibit condensed chromatin and scant cytoplasm, consistent with chronic lymphocytic leukemia (CLL) morphology. Along the left edge, characteristic smudge cells are visible, reflecting fragile lymphocytes commonly seen in CLL. A prolymphocyte located just below center presents with slightly irregular nuclear contours, more dispersed chromatin, a prominent nucleolus, and modestly increased cytoplasm. In CLL, prolymphocytes usually comprise less than 2% of neoplastic cells; when 10–15%, the term atypical CLL is used and carries implications of aberrant immunophenotype, cytogenetic abnormalities, cytopenias, refractoriness to therapy, and worse prognosis. If prolymphocytes predominate, consideration should be given to B-cell prolymphocytic leukemia. This image demonstrates key diagnostic features including lymphoid morphology, prolymphocytic variant, and smear artifacts. Clinically, these findings correlate with lymphocytosis and potential anemia or thrombocytopenia in affected patients. Definitive characterization requires ancillary testing such as flow cytometry, immunophenotyping, and cytogenetics. The morphology supports a differential diagnosis that includes CLL with prolymphocytic transformation, atypical CLL, and B-PLL, guiding prognosis and treatment planning.

Imaging modality: Brightfield light microscopy of a Wright-Giemsa stained peripheral blood smear. The slide shows a predominant population of small to medium-sized lymphoid cells with scant pale cytoplasm and dense, clumped chromatin. Numerous cells exhibit mature-appearing B lymphocyte morphology. A fine background of erythrocytes and occasional smudge cells is present, with no overt blasts or granulocytic abnormalities. The overall pattern is lymphocytosis with a monomorphic lymphocytic population, compatible with monoclonal B-cell lymphocytosis (MBL) or the chronic lymphocytic leukemia (CLL) spectrum. Immunophenotypic confirmation (CD5+, CD23+, CD19+, surface Ig) is typically required for definitive classification, but is outside the scope of this image. The cluster appears relatively uniform, suggesting clonality rather than reactive lymphocytosis. Genetic associations commonly reported with CLL/MBL include 13q14 deletion and trisomy 12, though such findings require molecular testing. Clinically, CLL is defined by an absolute lymphocyte count ≥5.0 x 10^9/L in peripheral blood for at least 3 months; values below this threshold meet criteria for MBL. The image illustrates morphologic correlates of indolent clonal B-cell expansions and underscores the need to integrate flow cytometry and cytogenetics for diagnosis, prognosis, and management decisions. This image is educational for hematology, pathology, and cytology reference libraries.

Bone marrow aspirate smear analyzed by light microscopy with high magnification reveals marrow involvement by chronic lymphocytic leukemia (CLL) cells. The predominant population consists of small, dark lymphocytes with scant cytoplasm and condensed, clumped nuclear chromatin, producing high nuclear-to-cytoplasmic ratios. Occasional larger forms and prolymphocytes may be present but are uncommon. A consistent finding is the relative scarcity of cytoplasm and uniform round to slightly irregular nuclei among the bulk of lymphoid cells. The smear may show scattered megakaryocytes, reflecting concurrent hematopoietic activity within the aspirate. Morphology mirrors circulating leukemic cells, consistent with systemic disease. Clinically, such marrow infiltration is associated with cytopenias and advanced disease stage, especially when diffuse, solid infiltration predominates in core biopsy patterns; these patterns correlate with adverse prognosis and with expression of prognostic markers such as ZAP-70. The image corresponds to a high-magnification field intended to document cellular detail rather than architectural marrow patterns. Diagnostic significance lies in confirming lymphoid marrow involvement by CLL, quantifying blast equivalents is not applicable, and differentiating from other small B-cell neoplasms relies on adjunct flow cytometry, cytogenetics, and immunophenotyping. This representation is typical for educational, diagnostic, and research contexts describing CLL marrow morphology.

This medical infographic illustrates the comparative T-cell exhaustion phenotype of CD8+ T-cells in Chronic Lymphocytic Leukemia (CLL), contrasting peripheral blood (PB) versus lymph nodes (LN). The top section features anatomical diagrams of a blood vessel and a lymph node, each linked to a CD8+ T-cell illustration. Visual symbols indicate that CD8+ T-cells in the LN exhibit a higher density of surface markers PD-1 and CD69 and altered intracellular molecules (GzmB, TNFα, IFNγ, IL-2) compared to PB. The bottom section provides data summary boxes for 'T-cell activation' (CD69, CD137, GITR), 'Inhibitory receptors' (PD-1, CD244, Lag3), 'Cytokines' (IFNγ, IL-2, TNFα), 'Cytotoxic function' (CD107a, GzmB), and 'Cell distribution'. Blue arrow markers indicate a trend towards higher expression or prevalence in the lymph nodes for most markers, including exhausted cell populations (CD8+ TEMRA, Effector, and Memory T-cells). This diagram highlights that T-cell exhaustion in CLL is more severe in the lymphoid tissue microenvironment than in systemic circulation.

Peripheral blood smear from a patient with suspected chronic lymphocytic leukemia (CLL) shows a predominance of small, mature-appearing lymphocytes with scant cytoplasm and clumped nuclear chromatin, accompanied by fragile cells that readily disrupt during smear preparation, producing numerous smudge or basket cells visible on the slide. The image depicts a single smudge cell in the upper right, with numerous small darkly staining lymphocytes occupying the field. The smear was prepared with Wright-Giemsa stain and examined under light microscopy at high magnification (approximately 1000x total magnification with oil immersion). Clinically, CLL is defined by absolute mature lymphocytosis of ≥5.0 × 10^9/L sustained for ≥3 months, often asymptomatic and detected incidentally on complete blood count. Morphology alone is insufficient for diagnosis; immunophenotyping showing co-expression of CD5, CD19, CD23 with weak surface immunoglobulin and light chain restriction supports CLL diagnosis. Smudge cells result from fragile leukemic cells and reflect underlying cytoskeletal fragility, though they are not specific. The image illustrates typical features: monomorphic lymphocytes, scant cytoplasm, condensed chromatin, and absent prominent nucleoli. This finding has diagnostic significance, guiding further workup, including flow cytometry, cytogenetics, and molecular studies, to distinguish CLL from other chronic lymphoproliferative disorders such as small lymphocytic lymphoma (SLL), mantle cell lymphoma, prolymphocytic leukemia, and reactive lymphocytosis.

Peripheral blood smear from a patient with known chronic lymphocytic leukemia (CLL) showing autoimmune hemolytic anemia (AIHA). Brightfield microscopy of Wright-Giemsa stained smear at 1000x (oil immersion) reveals two dominant cell populations: numerous small mature lymphocytes typical of CLL and red blood cells showing spherocytic deformation. A smudge cell is evident just left of center, a classical clue for CLL. Red cells display reduced central pallor consistent with spherocytes, indicating intravascular or extravascular hemolysis driven by autoantibodies. The background shows mild polychromasia and rare nucleated RBCs, consistent with a robust reticulocyte response; the corrected reticulocyte count in this case is markedly elevated (>7%). Platelets are not significantly abnormal. These features collectively support autoimmune destruction of erythrocytes in the setting of CLL. Diagnostic significance lies in recognizing AIHA as a common autoimmune complication in CLL, with a clinical picture of sudden Hb decline and compensatory erythropoiesis. Differential considerations include drug-induced hemolysis, other causes of hemolytic anemia, or marrow infiltration by CLL. Clinical correlation includes therapy implications (steroids, rituximab) and close monitoring of hemolysis markers. This image is a valuable teaching resource for hematology morphology, AIHA in CLL, and differential diagnosis in anemia.

Imaging Modality: Brightfield light microscopy of a Wright-Giemsa stained peripheral blood smear. The primary subject is leukocytes from circulating blood, with focus on small mature-appearing lymphocytes and rare prolymphocytes. At center-right, several lymphocytes exhibit condensed chromatin and scant cytoplasm, consistent with chronic lymphocytic leukemia (CLL) morphology. Along the left edge, characteristic smudge cells are visible, reflecting fragile lymphocytes commonly seen in CLL. A prolymphocyte located just below center presents with slightly irregular nuclear contours, more dispersed chromatin, a prominent nucleolus, and modestly increased cytoplasm. In CLL, prolymphocytes usually comprise less than 2% of neoplastic cells; when 10–15%, the term atypical CLL is used and carries implications of aberrant immunophenotype, cytogenetic abnormalities, cytopenias, refractoriness to therapy, and worse prognosis. If prolymphocytes predominate, consideration should be given to B-cell prolymphocytic leukemia. This image demonstrates key diagnostic features including lymphoid morphology, prolymphocytic variant, and smear artifacts. Clinically, these findings correlate with lymphocytosis and potential anemia or thrombocytopenia in affected patients. Definitive characterization requires ancillary testing such as flow cytometry, immunophenotyping, and cytogenetics. The morphology supports a differential diagnosis that includes CLL with prolymphocytic transformation, atypical CLL, and B-PLL, guiding prognosis and treatment planning.

Imaging modality: Brightfield light microscopy of a Wright-Giemsa stained peripheral blood smear. The slide shows a predominant population of small to medium-sized lymphoid cells with scant pale cytoplasm and dense, clumped chromatin. Numerous cells exhibit mature-appearing B lymphocyte morphology. A fine background of erythrocytes and occasional smudge cells is present, with no overt blasts or granulocytic abnormalities. The overall pattern is lymphocytosis with a monomorphic lymphocytic population, compatible with monoclonal B-cell lymphocytosis (MBL) or the chronic lymphocytic leukemia (CLL) spectrum. Immunophenotypic confirmation (CD5+, CD23+, CD19+, surface Ig) is typically required for definitive classification, but is outside the scope of this image. The cluster appears relatively uniform, suggesting clonality rather than reactive lymphocytosis. Genetic associations commonly reported with CLL/MBL include 13q14 deletion and trisomy 12, though such findings require molecular testing. Clinically, CLL is defined by an absolute lymphocyte count ≥5.0 x 10^9/L in peripheral blood for at least 3 months; values below this threshold meet criteria for MBL. The image illustrates morphologic correlates of indolent clonal B-cell expansions and underscores the need to integrate flow cytometry and cytogenetics for diagnosis, prognosis, and management decisions. This image is educational for hematology, pathology, and cytology reference libraries.

This is a Wright–Giemsa stained bone marrow aspirate smear imaged by bright-field light microscopy at high magnification, showing a cytology-level field of hematopoietic cells. Nuclei are round to irregular with coarse chromatin; cells range from mature myeloid/erythroid elements to immature precursor forms. Clusters of cells and occasional smearing artefacts reflect aspirate preparation. Staining emphasizes nuclear detail and cytoplasmic basophilia, enabling assessment of lineage commitment, maturation, cellularity, and potential neoplastic involvement. The image is clinically relevant for evaluating marrow cellularity, dysplasia, and infiltration, and for distinguishing reactive hematopoiesis from malignant processes. Diagnostic significance lies in guiding ancillary studies such as flow cytometry, cytogenetics, and molecular testing. Potential educational and diagnostic applications include hematopathology training, differential diagnosis of acute leukemia and myelodysplastic syndrome, aplastic anemia evaluation, and assessment of marrow involvement by lymphoma. Clinically, correlate with CBC, differential counts, peripheral smear, and immunophenotyping to determine prognosis and treatment planning. Interpretation should consider sample quality and ancillary data to ensure accurate diagnosis.

High-magnification brightfield micrograph of a human bone marrow aspirate smear stained with Hematoxylin and Eosin, demonstrating dysplastic megakaryocytes in a hematopoietic background. The megakaryocytes exhibit atypical nuclear morphology, including multinucleation, irregular lobulation, and nuclear fragmentation, with variable cytoplasmic basophilia. Background cellularity shows concurrent dyserythropoiesis and dysplastic myeloid precursors consistent with a myelodysplastic spectrum. Overall architecture may be hypercellular or variably cellular, with scattered normal hematopoietic elements interspersed among abnormal cells. Features are most prominent in the megakaryocytic lineage, where dysplasia is a salient hallmark. The image illustrates morphologic criteria that support a diagnosis in the context of possible progression toward acute leukemia, and should be correlated with peripheral blood counts, marrow blast percentage, cytogenetic and molecular studies. Clinically, such dysplastic megakaryocytes are associated with cytopenias and splenomegaly, and approximately a fifth of patients with related myelodysplastic/myeloproliferative conditions progress to acute myeloid leukemia. This representation is valuable for educational, diagnostic, and research purposes, particularly in studies of megakaryocytic dysplasia, MDS/AML continuum, prognostication, and therapeutic planning focused on palliation and cytopenia management. Careful documentation of features and context enhances reproducibility, supports standardized reporting, and facilitates cross-institutional data sharing for outcome studies and biomarker-driven clinical trials.

Bone marrow aspirate smear analyzed by light microscopy with high magnification reveals marrow involvement by chronic lymphocytic leukemia (CLL) cells. The predominant population consists of small, dark lymphocytes with scant cytoplasm and condensed, clumped nuclear chromatin, producing high nuclear-to-cytoplasmic ratios. Occasional larger forms and prolymphocytes may be present but are uncommon. A consistent finding is the relative scarcity of cytoplasm and uniform round to slightly irregular nuclei among the bulk of lymphoid cells. The smear may show scattered megakaryocytes, reflecting concurrent hematopoietic activity within the aspirate. Morphology mirrors circulating leukemic cells, consistent with systemic disease. Clinically, such marrow infiltration is associated with cytopenias and advanced disease stage, especially when diffuse, solid infiltration predominates in core biopsy patterns; these patterns correlate with adverse prognosis and with expression of prognostic markers such as ZAP-70. The image corresponds to a high-magnification field intended to document cellular detail rather than architectural marrow patterns. Diagnostic significance lies in confirming lymphoid marrow involvement by CLL, quantifying blast equivalents is not applicable, and differentiating from other small B-cell neoplasms relies on adjunct flow cytometry, cytogenetics, and immunophenotyping. This representation is typical for educational, diagnostic, and research contexts describing CLL marrow morphology.

Histology image of Hurthle cell adenoma of the thyroid. This light microscopy slide is stained with Hematoxylin and Eosin (H&E) and shows a predominantly oncocytic (Hurthle) cell population arranged in sheets and microfollicular clusters. The cells are large and polygonal, with abundant granular eosinophilic cytoplasm rich in mitochondria, and round to oval nuclei with often prominent nucleoli. Nuclei may display mild atypia, but mitotic activity is scarce in this field. The lesion appears typically well circumscribed and encapsulated within thyroid parenchyma, with a benign architectural pattern; no definite invasive cords are evident in this view. Colloid material may be scant or variably present within trapping follicles. The surrounding stroma is modest, and vessels are not overtly infiltrated by tumor cells in this image. Clinically, Hurthle cell adenoma represents a benign neoplasm of uncertain function that can simulate carcinoma on cytology; therefore capsule integrity and absence of capsular or vascular invasion are essential for definitive classification. This image is instrumental for histopathology education, differential diagnosis with Hurthle cell carcinoma, and surgical planning discussions, and it supports terminology including oncocytic adenoma, Hurthle cell lesion, and thyroid follicular neoplasm. Further education and clinical correlation.